Before Lp(a) or its associated OxPL can be considered viable targets for therapeutic intervention in AS, prospective longitudinal studies are required to establish whether Lp(a) and OxPL are associated with disease progression—in addition to mechanistic work investigating the cellular mechanisms linking Lp(a) and OxPL with valvular calcification. This evidence concerns the gene LPA and aortic valve stenosis.